Here's a brief review of BMRA's results for quarter ending February 28, 1998.
Sales were $2,085,773 vs 2,303,353 (a decline of 9.4%, mostly due to LANZ poor sales performance).
Net income was 25,755 vs 99,857
Earnings per share were .01 vs .03
Each of the two last fiscal years BMRA has earned 0.12 per share.
With one quarter left in its current fiscal year, BMRA has earned 0.05 per share. Therefore, BMRA must earn 0.07 per share this last quarter to simply perform as well as last year.
The company has spent about (roughly) twice as much money on R&D this year as they did last year. This has affected earnings as much as anything. Hopefully, this investment will result in future earnings.
LANZ continues to disappoint, with sales and net income both declining.
It seems that only news will lift this stock in the near term, we aren't seeing enough growth to justify a higher stock price.
You can review the full 10Q for both companies at freeedgar.com |
